NeuroSense Therapeutics Ltd. Interest Received Classified As Investing Activities
NeuroSense Therapeutics Ltd. (NRSN) reported Interest Received Classified As Investing Activities of $178.00 thousand for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Cash Flow › Investing Activities
ifrs-full:InterestReceivedClassifiedAsInvestingActivities · last filed 2024-04-04
| Period end | Interest Received Classified As Investing Activities 6 month | Interest Received Classified As Investing Activities 12 month |
|---|---|---|
| 2023-12-31 | $178.00K 20-F · filed 2024-04-04 | |
| 2023-06-30 | $47.00K 6-K · filed 2023-08-16 | |
| 2022-12-31 | $49.00K 20-F · filed 2024-04-04 |